# A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia

> **NCT03806556** · PHASE1,PHASE2 · TERMINATED · sponsor: **Meghan McCormick** · enrollment: 11 (actual)

## Conditions studied

- Pediatric Cancer
- Thrombocytopenia
- Hemostatic Disorder
- Coagulation Defect; Acquired

## Interventions

- **DRUG:** Tranexamic Acid
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT03806556
- **Lead sponsor:** Meghan McCormick
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-04-22
- **Primary completion:** 2020-08-25
- **Final completion:** 2020-08-25
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Low accrual rate, strategic reasons
- **Last updated:** 2021-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03806556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03806556, "A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03806556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*